XEOU:LSE:LSE-db x-trackers MSCI Europe UCITS (USD)

ETF | Others |

Last Closing

USD 16.968

Change

0.00 (0.00)%

Market Cap

USD 0.36B

Volume

7.66K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.30 (+0.11%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-0.63 (-0.93%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.06 (+3.40%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+1.16%)

USD 553.83B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.18 (+1.07%)

USD 553.83B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+15.00 (+0.76%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.10 (-0.16%)

USD 266.08B
0QZO:LSE 0QZO

-0.50 (-0.49%)

USD 258.54B

ETFs Containing XEOU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.56% 78% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.56% 77% C+ 73% C
Trailing 12 Months  
Capital Gain 13.77% 71% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.77% 71% C- 70% C-
Trailing 5 Years  
Capital Gain 58.15% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.15% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.63% 72% C 73% C
Dividend Return 10.63% 71% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.01% 56% F 71% C-
Risk Adjusted Return 81.67% 89% A- 93% A
Market Capitalization 0.36B 65% D 48% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike